Category: News Feed

NCPA Members – Free Webinar for CE Credit on May 10th

NCPA Members—Free Webinar for CE credit on May 10th. Understand the major statutes and regulations impacting pharmacy compliance today. Get Tips to Be Proactively Compliant on a May 10 Webinar (& Earn CE) Over the past several years, government enforcement in

NCPA Advocacy Center Update – Week Ending May 6, 2017

Medicare Pharmacy Choice and Access Bill Introduced in the Senate: The Ensuring Seniors Access to Local Pharmacies Act, S. 1044, was introduced by Senators Shelley Moore Capito (R-WV), Sherrod Brown (D-OH), Tom Cotton (R-AK) and Joe Manchin (D-WV).  The bill

Keystone and PARD Gives Back

The employees of Keystone and PARD gave back today by volunteering their time at the Choice Foods pantry at KleinLife on Jamison Avenue in Philadelphia.  Stocking shelves and filling orders gave the team a chance to pay it forward. From

Interesting Article on Pet Meds

https://www.linkedin.com/pulse/pet-medication-market-growing-joshua-pirestani?trk=v-feed&lipi=urn%3Ali%3Apage%3Ad_flagship3_detail_base%3B4sEiRQyi%2FPzOR4v46DJsSw%3D%3D  

Prescription Drug Monitoring Program (PDMP)

General Q&A Please click here for more information on the Prescription Drug Monitoring Program.

A Secret Profit Formula Love by Drug Middlemen Is at Risk

https://www.bloomberg.com/news/articles/2017-04-26/secret-profit-formulas-at-risk-as-drug-middleman-loses-contract    

NCPA Advocacy Center Update – Week Ending April 29, 2017

NCPA Congressional Pharmacy Fly-In Wrap Up:  NCPA held its 49th annual meeting with over 200 independent community pharmacists visiting Capitol Hill in Washington, D.C. this week to share with Congress real solutions to the problem of skyrocketing prescription drugs.  The

How to Build a Thriving Vaccination Program with Prescribe Wellness

Today’s patients are increasingly looking to their local community pharmacy to be a one-stop shop for many health and wellness needs, especially vaccinations. Pharmacists – are you taking advantage of this opportunity? Join Prescribe Wellness on 4/25 at 10 am

How The Small Neighborhood Pharmacy Prevails

Independent Pharmacies can stay relevant in today’s world by looking at their overall business and asking how they can best service their customers. Great article exploring ways to accomplish this. http://www.bizjournals.com/triangle/news/2017/04/24/how-the-small-neighborhood-pharmacy-prevails.html

Medication Adherence

Medication Adherence is a critical part of pharmacy business profitability. But why should the person who’s been prescribed the medication care? Non-adherence to prescriptions causes some 125,000 deaths a year in the United States alone. Great article explaining reasons for

NCPA Advocacy Center Update – Week Ending April 22, 2017

You Can Still Join the Fight Against PBMs. Come to D.C for the Congressional Fly-In April 26 & 27:  Emails, phone calls, and faxes to your elected officials in Washington can get their attention, but face-to-face meetings carry the greatest

May is an Important Health-Related Month

The month of May is the most important health-related month of the year, loaded with key opportunities to generate content for your website and social media accounts as well as end-caps and in-store displays: o Arthritis Month: Feature an end-cap

PARD & Keystone Represents at Legislative Day in Harrisburg

Great day in Harrisburg for Pharmacy Legislative Day!  PARD and Keystone Pharmacy Leadership along with Keystone Independent Pharmacy Owners went in like a force to be reckoned with to speak to State Legislators of the challenges facing Pharmacy today.

Another reason why May is the biggest month of the year for pharmacy?

May kicks off Mother’s Day, graduation season, the start of wedding and anniversary season, and the beginning of Father’s Day shopping season. It’s time to freshen up your greeting card department and get ready for the rush! Mother’s Day is

Cardinal Health’s Unhappy Profit Surprise: The Coevolution of Pharmacy Buying Groups and Wholesaler Economics

Success of buying groups to hold wholesalers accountable on generic pricing is well outlined in this article. Not only does Keystone work directly with wholesalers to ensure generic pricing is kept competitive, we offer a wide range of other negotiated

National Prescription Drug Take Back Day

Have unused prescriptions? Don’t throw in the trash! Dispose safely during National Prescription Drug Take Back Day on April 29 from 10am-2pm. Click link below for locations offering this program. https://apps.deadiversion.usdoj.gov/NTBI/ntbi-pub.pub?_flowExecutionKey=_cDB28A69B-7278-BEA4-32BB-F3BE06D40D32_k02B2F779-B902-CE99-2881-C9C0D2F9A339    

NCPA Advocacy Center Update – Week Ending April 15, 2017

Specialty Rxs Require a Special Dispensing Fee Pharmacy Groups Tell CMS:  Concerned that states may not fully cover the cost of acquiring and dispensing Medicaid specialty drugs, NCPA, NACDS and the  National Association of Specialty Pharmacy  (NASP) wrote to CMS

The State of Specialty Pharmacy Accreditation in 2017

Independent Pharmacies—Specialty Pharmacy is a growing segment. Great article that provides resource links for accreditation. http://www.drugchannels.net/2017/04/exclusive-update-state-of-specialty.html

Maryland Lawmakers Approve Bill to Fight Drug Price-Gouging

Click on the link below. http://www.reuters.com/article/us-maryland-drugs-idUSKBN17D2O6

Warning: Be alert to any unwarranted phone calls or deliveries from Xtreme Office Products

The picture attached is from an invoice on an ink cartridge for Lexmark printer at Whitehall Pharmacy. The pharmacy did not order this and when they called to say they did not order it and it was the wrong size

NCPA Advocacy Center Update – Week Ending April 8, 2017

Medicare Pharmacy Choice and Access House Bill Introduced This Week: The Ensuring Seniors Access to Local Pharmacies Act, H.R. 1939, was introduced by Reps. Morgan Griffith (R-VA) and Peter Welch (D-VT) on April 5th. The bill would allow community pharmacies

Check us out on Facebook!

Take a moment to check out our Facebook page at https://www.facebook.com/kpparx Give us a LIKE and ask other Independent Pharmacists to do the same. Write a review. Tell us what concerns you as an Independent Pharmacist. Get involved. Go ahead, check

NCPA Advocacy Center Update – Week Ending April 1, 2017

Your Member of Congress is Coming Home for Two Weeks:  Consider this an opportunity to invite your member of Congress to visit your pharmacy between April 8 and April 22 and brief him or her about PBMs. Here are details:

NCPA Advocacy Center Update – Week Ending March 25, 2017

Come Give Congress a Piece of Your Mind at the Congressional Pharmacy Fly-In April 26-27:  We are filling the halls of Congress April 26-27 with independent community pharmacies who are passionate about their patients and their practice and are tired

NCPA Advocacy Center Update – Week Ending March 11, 2017

ACA Repeal Marked up in the House Committees of Jurisdiction: The House Energy and Commerce and Ways and Means Committees marked up their respective instructions to the Budget Committee on party line votes after exhaustive sessions in both committees this

NCPA Advocacy Center Update – Week Ending March 4, 2017

Generic Drug Payment Bill Introduced in the U.S. House of Representatives:  Bipartisan legislation to increase transparency in generic drug payments in taxpayer-funded federal health programs and preserve patient access to local community pharmacies was introduced in the House this week

NCPA Advocacy Center Update – Week Ending February 25, 2017

NCPA Hosts DIR Stakeholder Call:  This week NCPA hosted a call with industry partners providing an update on recent developments regarding NCPA’s efforts on pharmacy DIR fees.  Highlights of the briefing: Overview of recent Centers for Medicare & Medicaid Services

NCPA Advocacy Center Update – Week Ending February 18, 2017

House/Senate DIR Bills Introduced: This week, Reps. Morgan Griffith (R-Va.) and Peter Welch (D-Vt.), along with 16 of their colleagues, introduced H.R. 1038, the “Improving Transparency and Accuracy in Medicare Part D Drug Spending Act,” that would prohibit retroactive pharmacy

NCPA Advocacy Center Update – Week Ending February 11, 2017

NCPA Responds to PBM Efforts to Limit Potential Reforms:  An apparently leaked memorandum has surfaced from Mark Merritt, president and CEO of the Pharmaceutical Care Management Association (PCMA), to the association’s board of directors. It outlines PCMA’s strategies to mitigate

NCPA Advocacy Center Update – Week Ending January 28, 2017

NCPA Supports House Bill Recognizing Pharmacists as Health Care Providers:  This week NCPA endorsed H.R. 592, the Pharmacy and Medically Underserved Areas Enhancement Act, which was introduced by U.S. Reps. Brett Guthrie (R-Ky.), G.K. Butterfield (D-N.C.), Tom Reed (R-N.Y.) and

NCPA Advocacy Center Update – Week Ending January 21, 2017

NCPA Members List Top 2017 Political Priorities:   For the fourth consecutive year, NCPA has asked its members to rank their most important legislative and regulatory priorities. The top issue chosen by respondents is to end the retroactive nature of DIR

NCPA Advocacy Center Update – SPECIAL ALERT – January 19, 2017

Hi all –NCPA is pleased to report that CMS released an analysis related to Part D DIR fees and the impact of these fees on the Part D program today.  The CMS analysis is an important step toward greater transparency

NCPA Advocacy Center Update – Week Ending January 14, 2017

NCPA Asks President-elect Trump to Scrutinize Pharmacy Benefit Managers in Review of Prescription Drug Prices:  This week NCPA sent a letter to President-elect Donald J. Trump urging his Administration to examine the role pharmacy benefit managers (PBMs) play in escalating

NCPA Advocacy Center Update – Week Ending December 24, 2016

DEA Revises Registrant Renewal Policy:  Heeding the concerns of NCPA and other registrants, the DEA has quickly revised a recently-issued policy change on renewal applications that could have decreased patient access to controlled substances and had audit implications for pharmacies. Starting

PPA Presents Mel Brodsky with Mortar and Pestle Award

Mel Brodsky – Mortar and Pestle Award

NCPA Advocacy Update – Week Ending October 1, 2016

Widespread Support for Ban on Part D Retroactive DIRs:  NCPA and nearly 100 other pharmacy stakeholder organizations have expressed their support to the key lawmakers behind legislation that would prohibit retroactive DIR pharmacy fees on Medicare Part D clean claims.

Pharmacy Benefit Manager (PBM) – video

Please watch the attached video from healthNsight Animated Video healthNsight Animated Video 2

The Pulse – Winter Edition – Philadelphia

Please see here for the winter edition of The Pulse.

PPA Produces Videos on PBM-Related Issues

PPA has produced three short videos to assist Pennsylvania pharmacists, student pharmacists, lawmakers, the public, and more in understanding the need for oversight of PBMs, MAC transparency and pharmacy audit integrity in Pennsylvania. These videos feature PPA members and staff;

Rite Aid of California Agreed to Pay More Than $498,000 to Settle Consumer Protection Lawsuit

Story Published: Jun 30, 2014 at 4:19 PM PDT Story Updated: Jun 30, 2014 at 4:19 PM PDT SAN DIEGO (CNS) – Rite Aid of California agreed to pay more than $498,000 to settle a consumer protection lawsuit, alleging its

Pharmacist Reed Finishes Second for GOP Nomination to West Virginia U.S. House Seat

NCPA member Ken Reed, running in his first political race, took second place in a field of seven seeking the Republican nomination in West Virginia’s 2nd congressional district. Reed received 22% of the vote in the May 13 primary to

Pharmacist Carter in Runoff for GOP Nomination to Georgia U.S. House Seat

NCPA member Buddy Carter finished first among six contenders for the Republican nomination in Georgia’s 1st congressional district. Carter took 36.2% of the vote in the May 20 primary. He’ll face Bob Johnson, a surgeon and ex-Army Ranger, who finished

Labor Department to Study PBMs

An advisory panel that makes policy recommendations to the Secretary of Labor is looking into PBM compensation and fee disclosure. One area of questioning at a three-day meeting planned in June: “…are PBMs incentivized to structure formularies to encourage the

New ‘Track-and-Trace’ Rule Moving Ahead

NCPA represented independent community pharmacy interests at a recent FDA workshop on its proposed prescription drug tracking system. Manufacturers, wholesalers, and dispensers discussed implementation of a new “track-and-trace” supply chain security system required by law. FDA must issue a draft

Support Picks Up for Legislation to Open Preferred Networks

Seven House members are now signed on to bipartisan legislation designed to bring fairness to preferred networks for pharmacies and patients. Initiated by Reps. Griffith (R-Va.) and Welch (Vt.) on May 6, now they have been joined on H.R. 4577

Medicare Will Require MAC Transparency as NCPA Urged

NCPA has commended Medicare for taking positive steps on generic drug reimbursement procedures by Part D plans, actions NCPA has tirelessly advocated for years. Last Monday CMS said for the 2016 plan year it would require sponsors to both disclose

Updates to DPW Website

Below are recent updates to the DPW Website. Please check the “What’s New” page on the website frequently for new additions. 01-14-17 A Medical Assistance Bulletin entitled Prior Authorization of Kalydeco (ivacaftor) – Pharmacy Services 01-14-18 A Medical Assistance Bulletin

Glaxosmithkline Recalls Alli

  On March 27, 2014  GlaxoSmithKline (GSK) Consumer Healthcare issued a recall on all alli® weight loss products from U.S. and Puerto Rico retailers due to evidence that some of the packages have been tampered with. Consumers in seven states

Nova Products, Inc. Issues Voluntary Nationwide Recall of Dietary Supplements with Undeclared Active Pharmaceutical Ingredients

On March 27, 2014 Nova Products Inc of Aston, Pennsylvania issued a nationwide recall of  several lots of its natural supplements: African Black Ant (Lot# 2006-000926), Black Ant (Lot# 2006-3627878), XZen Gold (Lot# 130310GL), ZXen Platinum (Lot# 130520PL), XZen 1200

NCPA Seeks Congressional Probe of “Preferred Pharmacy” Part D Plans

The Senate and House Small Business committees should examine the unintended consequences for independent community pharmacies and patients that have resulted from Medicare Part D “preferred pharmacy” prescription drug plans, NCPA told lawmakers last week. “Small business community pharmacies across

Top